Updates in the treatment of ocular allergies

References

• KeyBAllergy and allergic diseases. Part IN Engl J Med2001344303711136958
   PubMed Web of Science ®Google Scholar
• OnoSJAbelsonMBAllergic conjunctivitis update on pathophysiology and prospects for future treatmentJ Allergy Clin Immunol2005115111812215637556
   PubMed Web of Science ®Google Scholar
• HussainAAwanHKhanMDPrevalence of non-vision-impairing conditions in a village in Chakwal district, Punjab, PakistanOphthalmic Epidemiol200411541342615590587
   PubMed Web of Science ®Google Scholar
• LeonardiAMotterleLBortolottiMAllergy and the eyeClin Exp Immunol2008153Suppl 1172118721324
   PubMed Web of Science ®Google Scholar
• IbáñezMDGardeJMAllergy in patients under fourteen years of age in AlergológicaJ Investig Allergol Clin Immunol200919Suppl 26168
   Google Scholar
• SaariKMKariOHaahtelaTNonallergic eosinophilic conjunctivitisExpert Rev Ophthalmol200723331333
   Google Scholar
• KariOHaahtelaTLainePCellular characteristics of non-allergic eosinophilic conjunctivitisActa Ophthalmol201088224525019930216
   PubMed Web of Science ®Google Scholar
• ReitamoSRemitzAHaahtelaTHit early and hit hard in atopic dermatitis and not only in asthmaAllergy200964450350419317838
   PubMed Web of Science ®Google Scholar
• MaloJ-LLemiéreCDesjardinsACartierAPrevalence and intensity of rhinoconjunctivitis in subjects with occupational asthmaEur Respir J1997107151315159230239
   PubMed Web of Science ®Google Scholar
• IraniAMOcular mast cells and mediatorsImmunol Allergy Clin North Am20082812542v18282544
   PubMed Web of Science ®Google Scholar
• IkomaAAnalysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: mechanisms and management of itch in atopic dermatitisJ Pharmacol Sci2009110326526919609064
   PubMed Web of Science ®Google Scholar
• ScuriMSamsellLPiedimonteGThe role of neurotrophins in inflammation and allergyInflamm Allergy Drug Targets20109317318020553229
   PubMedGoogle Scholar
• McGillJIHolgateSTChurchMKAndersonDFBaconAAllergic eye disease mechanismsBr J Ophthalmol19988210120312149924312
   PubMed Web of Science ®Google Scholar
• SpencerLASzelaCTPerezSAHuman eosinophils constitutively express multiple Th1, Th2 and immunoregulatory cytokines that are secreted rapidly and differentiallyJ Leukoc Biol200985111712318840671
   PubMed Web of Science ®Google Scholar
• CorthayAHow do regulatory T cells work?Scand J Immunol200970432633619751267
   PubMed Web of Science ®Google Scholar
• GillDTanPHInduction of pathogenic cytotoxic T lymphocyte tolerance by dendritic cells: a novel therapeutic targetExpert Opin Ther Targets201014879782420560799
   PubMed Web of Science ®Google Scholar
• FukushimaAOzakiAFukataKIshidaWUenoHAg-specific recognition, activation, and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitisInvest Ophthalmol Vis Sci200344104366437414507881
   PubMed Web of Science ®Google Scholar
• KariOSaloOPHalmepuroLSuvilehtoKTear histamine during allergic conjunctivitis challengeGraefes Arch Clin Exp Ophthalmol1985223260622408967
   PubMed Web of Science ®Google Scholar
• de PaulisAStellatoCCirilloRCiccarelliAOrienteAMaroneGAnti-inflammatory effect of FK-506 on human skin mast cellsJ Invest Dermatol19929967237281281861
   PubMed Web of Science ®Google Scholar
• ReynoldsNJAl-DarajiWICalcineurin inhibitors and sirolimus: mechanism of action and applications in dermatologyClin Exp Dermatol200227755556112464150
   PubMed Web of Science ®Google Scholar
• AramburuJHeitmanJCrabtreeGRCalcineurin: a central controller of signalling in eukaryotesEMBO Rep20045434334815060569
   PubMed Web of Science ®Google Scholar
• ReitamoSTacrolimus: a new topical immunomodulatory therapy for atopic dermatitisJ Allergy Clin Immunol2001107344544811240943
   PubMed Web of Science ®Google Scholar
• VirtanenHMReitamoSKariMKariOEffect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective studyActa Ophtalmol Scand2006845693695
   PubMedGoogle Scholar
• FratiFScuratiSPuccinelliPDevelopment of sublingual allergy vaccine for grass pollinosisDrug Des Devel Ther2010499105
   Web of Science ®Google Scholar
• OkuboKNagakuraTAnti-IgE antibody therapy for Japanese cedar pollinosis: omalizumab updateAllergol Int200857320520918724074
   PubMedGoogle Scholar
• AbramsonMJPuyRMWeinerJMInjection allergen immunotherapy for asthmaCochrane Database Syst Rev20108CD00118620687065
   PubMed Web of Science ®Google Scholar
• SkonerDGentileDBushRFasanoMBMcLaughlinAEschRESublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollenJ Allergy Clin Immunol2010125366066620153030
   PubMed Web of Science ®Google Scholar
• MallingH-JMontagutAMelacMEfficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitisClin Exp Allergy200939338739319134019
   PubMed Web of Science ®Google Scholar
• CanonicaGWBousquetJCasaleTSub-lingual immunotherapy: World Allergy Organization position paper 2009Allergy200964Suppl 9115920041860
   PubMed Web of Science ®Google Scholar
• BroideDHImmunomodulation of allergic diseaseAnnu Rev Med20096027929119630573
   PubMed Web of Science ®Google Scholar
• KoppMVHamelmannEZielenSDUAL study groupCombination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthmaClin Exp Allergy200939227127919016798
   PubMed Web of Science ®Google Scholar
• RemitzAVirtanenHMReitamoSKariOTacrolimus ointment in atopic blepharoconjunctivitis does not seem to elevate intraocular pressureActa Ophthalmol201018 [Epub ahead of print]
   Google Scholar
• ChenSLYanJWangFSTwo topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta analysis of randomized clinical trialsJ Dermatolog Treat201021314415620394490
   PubMed Web of Science ®Google Scholar
• EbiharaNOhashiYUchioEA large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitisJ Ocul Pharmacol Ther200925436537219441889
   PubMed Web of Science ®Google Scholar
• OhashiYEbiharaNFujishimaHA randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitisJ Ocul Pharmacol Ther201026216517420307214
   PubMed Web of Science ®Google Scholar
• KariOHaahtelaTConjunctival eosinophilia in atopic and non-atopic external eye symptomsActa Ophthalmol (Copenh)19927033353401636393
   PubMed Web of Science ®Google Scholar
• PonikausJUSherrisDAKephartGMFeatures of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma?J Allergy Clin Immunol2003112587788214610473
   PubMed Web of Science ®Google Scholar
• WalkerCBauerWBraunRKActivated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophiliaAm J Respir Crit Care Med19941504103810487921434
   PubMed Web of Science ®Google Scholar
• KariOAtopic conjunctivitis. A cytologic examinationActa Ophthalmol (Copenh)19886643813863195319
   PubMed Web of Science ®Google Scholar
• FeserAMahlerVPeriorbital dermatitis: causes, differential diagnoses and therapyJ Dtsch Dermatol Ges20108315916619751221
   PubMed Web of Science ®Google Scholar